LegitUser
Gluttonmaxxed gypsy from the council estate
- Joined
- Apr 30, 2024
- Posts
- 1,690
- Reputation
- 1,998
The plan begins with an Accutane cycle, continued until cumulative dosing clears existing acne, followed by a one-month continuation phase to solidify results. After this, Accutane dosing will be reduced to a maintenance level of 20 mg twice weekly. If side effects persist after one month of maintenance, the dosage will be further reduced to 20 mg once weekly. Once side effects resolve or after two months on maintenance (whichever is earlier), baseline bloodwork will be performed, including TSH, free T4, LH, FSH, testosterone, SHBG, LFTs, lipids, and FBC.
Testosterone enanthate will then be started at 100 mg twice weekly, with concurrent HCG administration at 250 IU every other day. After one month of testosterone use, bloodwork will be repeated to evaluate hormone levels, liver function, and lipid panels. If bloodwork is stable and side effects manageable, Masteron enanthate will be introduced at 300 mg per week, divided into two injections per week (every 3.5 days) to maintain stable hormone levels based on its half-life (~7–10 days). Bloodwork will be repeated 6 weeks after starting Masteron enanthate, allowing for 4-5 half-lives to ensure stable plasma levels. Masteron will be continued for 12 weeks, the common cycle length.
Upon discontinuing Masteron, a taper schedule will be followed: reduce dosage by ~50% weekly over a 3-week period (e.g., Week 1: 150 mg/week, Week 2: 75 mg/week, Week 3: discontinue). Following the Masteron taper, Proviron will be introduced at 25 mg orally daily for two months. Upon discontinuation, taper Proviron over a 1-2 week period due to its short half-life (~12 hours): Week 1: reduce to 12.5 mg daily; Week 2: take 12.5 mg every other day, then discontinue.
Testosterone enanthate will be discontinued at the end of the cycle. Due to its half-life (~4-5 days), endogenous testosterone suppression persists for up to 2-3 weeks. HCG use may be continued during this gap to maintain testicular function and ease the transition into PCT. Continue HCG at 250 IU every other day for 14 days after the last testosterone injection, then discontinue 2-3 days before starting PCT to avoid interference with HPG axis recovery.
PCT will begin approximately 2 weeks after stopping testosterone enanthate and HCG. Pre-PCT bloodwork will include testosterone, SHBG, LH, FSH, E2, and prolactin to establish recovery baselines. PCT will involve SERMs (e.g., tamoxifen at 20 mg daily or clomiphene at 25-50 mg daily) to stimulate endogenous testosterone production. Bloodwork measuring free testosterone, SHBG, and related markers will be conducted every 4 weeks to monitor recovery until normalization, with a full blood panel repeated 6 weeks after normalisation.
Testosterone enanthate will then be started at 100 mg twice weekly, with concurrent HCG administration at 250 IU every other day. After one month of testosterone use, bloodwork will be repeated to evaluate hormone levels, liver function, and lipid panels. If bloodwork is stable and side effects manageable, Masteron enanthate will be introduced at 300 mg per week, divided into two injections per week (every 3.5 days) to maintain stable hormone levels based on its half-life (~7–10 days). Bloodwork will be repeated 6 weeks after starting Masteron enanthate, allowing for 4-5 half-lives to ensure stable plasma levels. Masteron will be continued for 12 weeks, the common cycle length.
Upon discontinuing Masteron, a taper schedule will be followed: reduce dosage by ~50% weekly over a 3-week period (e.g., Week 1: 150 mg/week, Week 2: 75 mg/week, Week 3: discontinue). Following the Masteron taper, Proviron will be introduced at 25 mg orally daily for two months. Upon discontinuation, taper Proviron over a 1-2 week period due to its short half-life (~12 hours): Week 1: reduce to 12.5 mg daily; Week 2: take 12.5 mg every other day, then discontinue.
Testosterone enanthate will be discontinued at the end of the cycle. Due to its half-life (~4-5 days), endogenous testosterone suppression persists for up to 2-3 weeks. HCG use may be continued during this gap to maintain testicular function and ease the transition into PCT. Continue HCG at 250 IU every other day for 14 days after the last testosterone injection, then discontinue 2-3 days before starting PCT to avoid interference with HPG axis recovery.
PCT will begin approximately 2 weeks after stopping testosterone enanthate and HCG. Pre-PCT bloodwork will include testosterone, SHBG, LH, FSH, E2, and prolactin to establish recovery baselines. PCT will involve SERMs (e.g., tamoxifen at 20 mg daily or clomiphene at 25-50 mg daily) to stimulate endogenous testosterone production. Bloodwork measuring free testosterone, SHBG, and related markers will be conducted every 4 weeks to monitor recovery until normalization, with a full blood panel repeated 6 weeks after normalisation.
